MIMS news

MHRA updates adrenaline pen prescribing guidance

MHRA updates adrenaline pen prescribing guidance

GPs should prescribe two adrenaline auto-injectors...

Warn patients to report visual disturbances during steroid treatment, GPs advised

Warn patients to report visual disturbances during steroid treatment, GPs advised

Central serous chorioretinopathy (CSCR) is a retinal...

Temporary hepatitis B vaccination recommendations issued in light of vaccine shortages

Temporary hepatitis B vaccination recommendations issued in light of vaccine shortages

Global shortages of hepatitis B vaccines, including...

New rheumatoid arthritis treatment approved for NHS use

New rheumatoid arthritis treatment approved for NHS use

NICE has approved use of the JAK inhibitor baricitinib...

NICE updates guidance on use of bisphosphonates in osteoporosis

NICE updates guidance on use of bisphosphonates in osteoporosis

The new guidance supersedes parts of earlier guidance...

Fumaric acid ester now available as licensed oral psoriasis treatment

Fumaric acid ester now available as licensed oral psoriasis treatment

Prescribers treating patients with moderate to severe...

First triple combination inhaler launched for COPD

First triple combination inhaler launched for COPD

Trimbow is a 3-in-1 treatment for chronic obstructive...

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Kyntheum (brodalumab) injection is now available for...

COPD treatment approved for routine NHS use

COPD treatment approved for routine NHS use

NICE has approved roflumilast (Daxas) for use within...

NICE approves alternative biologic for Crohn's disease

NICE approves alternative biologic for Crohn's disease

Patients with moderate to severe Crohn's disease should...

Pregabalin prescribing restrictions lifted

Pregabalin prescribing restrictions lifted

Pregabalin can now be prescribed generically for the...

Sufentanil: self-administered opioid for post-operative pain

Sufentanil: self-administered opioid for post-operative pain

Zalviso (sufentanil) is licensed to treat with acute...

Rolapitant: a new option for chemotherapy-induced nausea and vomiting

Rolapitant: a new option for chemotherapy-induced nausea and vomiting

Varuby (rolapitant) is a new NK1 antagonist...

New vaccination option for meningitis B

New vaccination option for meningitis B

Trumenba is now one of two meningitis B vaccines available...

Insulin pen cartridge holders recalled over breakage concerns

Insulin pen cartridge holders recalled over breakage concerns

Patients with diabetes who use the NovoPen Echo or...

New obesity treatment targets appetite and reward pathways in the brain

New obesity treatment targets appetite and reward pathways in the brain

Mysimba (naltrexone/bupropion) can be used alongside...

Cardiovascular warning for rosacea gel

Cardiovascular warning for rosacea gel

Patients using the topical rosacea treatment brimonidine...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

New antibody prevents recurrence of Clostridium difficile infection

New antibody prevents recurrence of Clostridium difficile infection

Zinplava (bezlotoxumab) is a human monoclonal antibody...

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI (salmeterol/fluticasone) is indicated...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases